Abstract
Several research groups have utilized dental pulp stem cells for numerous studies as treatment modality for Parkinson’s disease (PD). However, the roles of dental pulp stem cells in governing the Parkinson’s disease inflammatory microenvironment remain to be evaluated. In this article, we elaborate the method where we can investigate the effects of dental pulp stem cells on neurons and microglia in an in vitro inflammatory microenvironment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Walker L, Stefanis L, Attems J (2019) Clinical and neuropathological differences between Parkinson’s disease, Parkinson’s disease dementia and dementia with Lewy bodies—current issues and future directions. J Neurochem. https://doi.org/10.1111/jnc.14698
Parihar A, Parihar P, Solanki I, Parihar MS (2019) Alpha synuclein and Parkinson’s disease. In: Pathology, prevention and therapeutics of neurodegenerative disease. Springer, Singapore, pp 1–14
Palmer C, Coronel R, Bernabeu-Zornoza A, Liste I (2019) Therapeutic application of stem cell and gene therapy in Parkinson’s disease. In: Pathology, prevention and therapeutics of neurodegenerative disease. Springer, Singapore, pp 159–171
Abu Kasim NH, Govindasamy V, Gnanasegaran N, Musa S, Pradeep PJ, Srijaya TC, Aziz ZACA (2015) Unique molecular signatures influencing the biological function and fate of post-natal stem cells isolated from different sources. J Tissue Eng Regen Med 9(12):E252–E266
Jayaraman P, Govindasamy V, Gnanasegaran N, Kunasekaran W, Vasanthan P, Musa S, Kasim NHA (2016) Expression patterns of immune genes in long-term cultured dental stem cells. Clin Oral Investig 20(1):109–116
Gnanasegaran N (2019) Myriad applications of dental pulp stem cells. Arq Bras Oftalmol 82(3):258
Gnanasegaran N, Govindasamy V, Musa S, Kasim NHA (2016) ReNCell VM conditioned medium enhances the induction of dental pulp stem cells into dopaminergic like cells. Cytotechnology 68(2):343–353
Gnanasegaran N, Govindasamy V, Kathirvaloo P, Musa S, Abu Kasim NH (2018) Effects of cell cycle phases on the induction of dental pulp stem cells toward dopaminergic-like cells. J Tissue Eng Regen Med 12(2):e881–e893
Gnanasegaran N, Govindasamy V, Mani V, Abu Kasim NH (2017) Neuroimmunomodulatory properties of DPSCs in an in vitro model of Parkinson’s disease. IUBMB Life 69(9):689–699
Bindal P, Ramasamy TS, Kasim NHA, Gnanasegaran N, Chai WL (2018) Immune responses of human dental pulp stem cells in lipopolysaccharide-induced microenvironment. Cell Biol Int 42(7):832–840
Acknowledgments
This work was supported by University of Malaya, Kuala Lumpur, Malaysia. Authors thank scientific input and relevant discussions from Envirotransgene® Global, Chennai, India.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media New York
About this protocol
Cite this protocol
Gnanasegaran, N., Thimiri Govinda Raj, D.B., Arumugam, S. (2019). Method for Evaluating Neuromodulatory Properties of Dental Pulp Stem Cell as an In Vitro Model for Parkinson’s Disease. In: Turksen, K. (eds) Stem Cell Nanotechnology. Methods in Molecular Biology, vol 2125. Humana, New York, NY. https://doi.org/10.1007/7651_2019_261
Download citation
DOI: https://doi.org/10.1007/7651_2019_261
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0359-8
Online ISBN: 978-1-0716-0360-4
eBook Packages: Springer Protocols